US Retinal Vein Occlusion Market

ID: MRFR/Pharma/11747-HCR
100 Pages
Satyendra Maurya
Last Updated: April 06, 2026
US Retinal Vein Occlusion Market Research Report: By Type (Branch Retinal Vein Occlusion, Central Retinal Vein Occlusion, Hemiretinal Vein Occlusion), By Treatment Approach (Laser Therapy, Intravitreal Injections, Surgery), By End User (Hospitals, Ophthalmology Clinics, Ambulatory Surgical Centers) and By Distribution Channel (Direct Sales, Retail Pharmacies, Online Pharmacies) - Growth & Industry Forecast 2025 To 2035
US Retinal Vein Occlusion Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.25%
2024 Market Size$ 410.82 Million
2025 Market Size$ 436.5 Million
2035 Market Size$ 800 Million
Key Players
Regeneron Pharmaceuticals
Novartis
Bayer
Roche
Allergan
Santen Pharmaceutical
Trends
  • Emergence of Novel Therapies
  • Increased Patient Awareness
  • Integration of Telemedicine
Opportunities
  • Rising Incidence of Retinal Disorders
  • Increased Focus on Preventive Eye Care
  • Advancements in Diagnostic Technologies
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Medical Device, BY Type (USD Million)
      1. 4.1.1 Branch Retinal Vein Occlusion
      2. 4.1.2 Central Retinal Vein Occlusion
      3. 4.1.3 Hemiretinal Vein Occlusion
    2. 4.2 Medical Device, BY Treatment Approach (USD Million)
      1. 4.2.1 Laser Therapy
      2. 4.2.2 Intravitreal Injections
      3. 4.2.3 Surgery
    3. 4.3 Medical Device, BY End User (USD Million)
      1. 4.3.1 Hospitals
      2. 4.3.2 Ophthalmology Clinics
      3. 4.3.3 Ambulatory Surgical Centers
    4. 4.4 Medical Device, BY Distribution Channel (USD Million)
      1. 4.4.1 Direct Sales
      2. 4.4.2 Retail Pharmacies
      3. 4.4.3 Online Pharmacies
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Medical Device
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Regeneron Pharmaceuticals (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Novartis (CH)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Bayer (DE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Roche (CH)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Allergan (IE)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Santen Pharmaceutical (JP)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Apellis Pharmaceuticals (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Horizon Therapeutics (IE)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY TYPE
    3. 6.3 US MARKET ANALYSIS BY TREATMENT APPROACH
    4. 6.4 US MARKET ANALYSIS BY END USER
    5. 6.5 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
    9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
    11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
    12. 6.12 MEDICAL DEVICE, BY TYPE, 2024 (% SHARE)
    13. 6.13 MEDICAL DEVICE, BY TYPE, 2024 TO 2035 (USD Million)
    14. 6.14 MEDICAL DEVICE, BY TREATMENT APPROACH, 2024 (% SHARE)
    15. 6.15 MEDICAL DEVICE, BY TREATMENT APPROACH, 2024 TO 2035 (USD Million)
    16. 6.16 MEDICAL DEVICE, BY END USER, 2024 (% SHARE)
    17. 6.17 MEDICAL DEVICE, BY END USER, 2024 TO 2035 (USD Million)
    18. 6.18 MEDICAL DEVICE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    19. 6.19 MEDICAL DEVICE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY TREATMENT APPROACH, 2025-2035 (USD Million)
      3. 7.2.3 BY END USER, 2025-2035 (USD Million)
      4. 7.2.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Retinal Vein Occlusion Market Segmentation

US Retinal Vein Occlusion Market By Type (USD Million, 2025-2035)

  • Branch Retinal Vein Occlusion
  • Central Retinal Vein Occlusion
  • Hemiretinal Vein Occlusion

US Retinal Vein Occlusion Market By Treatment Approach (USD Million, 2025-2035)

  • Laser Therapy
  • Intravitreal Injections
  • Surgery

US Retinal Vein Occlusion Market By End User (USD Million, 2025-2035)

  • Hospitals
  • Ophthalmology Clinics
  • Ambulatory Surgical Centers

US Retinal Vein Occlusion Market By Distribution Channel (USD Million, 2025-2035)

  • Direct Sales
  • Retail Pharmacies
  • Online Pharmacies

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.